271 related articles for article (PubMed ID: 33614485)
1. Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients.
Wang Y; Zhou W; Ma S; Guan X; Zhang D; Peng J; Wang X; Yuan L; Li P; Mao B; Kang P; Li D; Zhang C; Jia W
Front Oncol; 2020; 10():597877. PubMed ID: 33614485
[TBL] [Abstract][Full Text] [Related]
2. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
3. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W
J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
5. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
Front Genet; 2021; 12():569318. PubMed ID: 33796128
[No Abstract] [Full Text] [Related]
6. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
7. Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Liang R; Zhi Y; Zheng G; Zhang B; Zhu H; Wang M
Onco Targets Ther; 2019; 12():157-168. PubMed ID: 30613154
[TBL] [Abstract][Full Text] [Related]
8. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses.
Xu X; Zhou S; Tao Y; Zhong Z; Shao Y; Yi Y
Cell Div; 2023 Jun; 18(1):10. PubMed ID: 37355624
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y
Front Genet; 2021; 12():720421. PubMed ID: 34490046
[TBL] [Abstract][Full Text] [Related]
11. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Xiang Z; Chen X; Lv Q; Peng X
Front Genet; 2021; 12():697819. PubMed ID: 34408772
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
13. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
14. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
15. Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment.
Liu Q; Bao H; Zhang S; Song T; Li C; Sun G; Sun X; Fu T; Wang Y; Liang P
Front Genet; 2023; 14():1096792. PubMed ID: 36911393
[No Abstract] [Full Text] [Related]
16. Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma.
Li T; Tong H; Zhu J; Qin Z; Yin S; Sun Y; Liu X; He W
Front Med (Lausanne); 2021; 8():777507. PubMed ID: 35083240
[TBL] [Abstract][Full Text] [Related]
17. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
Front Oncol; 2020; 10():590352. PubMed ID: 33392085
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B
Front Oncol; 2021; 11():726745. PubMed ID: 34540695
[TBL] [Abstract][Full Text] [Related]
19. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
Front Oncol; 2020; 10():578809. PubMed ID: 33330055
[TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]